Acemetacin

This classification denotes a nonsteroidal antiinflammatory drug with the molecular formula C21H18ClNO6, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 5V141XK28X, chemically known as 1h-indole-3-acetic acid, 1-(4-chlorobenzoyl)-5-methoxy-2-methyl-, carboxymethyl ester but generally known as acemetacin, which bears US NIH Compound Identifier 1981. European Medicines Agency schedules Acemetacin in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB05209MIG. The term ACEMETACIN is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 29, No. 10 1975, List 15). World Health Organization schedules acemetacin in its Anatomical Therapeutic Chemical (ATC) Classification. ACEMETACIN is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule acemetacin under HS 29339990 and SITC 51577. As of Q4 2014, ACEMETACIN remains the US FDA Preferred Term for this commodity. Acemetacin bears US NLM identifiers UMLS ID C0050409 and NCI Concept Code C73068. SMILES: CLC1CCC(C(=O)N2C(C(C3C2CCC(OC)C3)CC(=O)OCC(=O)O)C)CC1.